Bio-Works Technologies AB (publ) (FRA:1BD)

Market Cap	29.60M +197.2%
Revenue (ttm)	5.83M +107.0%
Net Income	-1.41M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	59
Open	0.2760
Previous Close	0.2710
Day's Range	0.2760 - 0.2760
52-Week Range	0.0860 - 0.3430
Beta	n/a
RSI	44.65
Earnings Date	May 13, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2006
• Employees: 26
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1BD

Financial Performance

In 2025, Bio-Works Technologies AB's revenue was 63.11 million, an increase of 107.01% compared to the previous year's 30.49 million. Losses were -15.25 million, -59.19% less than in 2024.

Financial numbers in SEK